DrugPatentWatch Database Preview
GENVOYA Drug Profile
Which patents cover Genvoya, and what generic alternatives are available?
Genvoya is a drug marketed by Gilead Sciences Inc and is included in one NDA. There are fourteen patents protecting this drug.
This drug has six hundred and twenty-eight patent family members in fifty-nine countries.
The generic ingredient in GENVOYA is cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate profile page.
Summary for GENVOYA
| International Patents: | 628 |
| US Patents: | 14 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Clinical Trials: | 18 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for GENVOYA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for GENVOYA |
| DailyMed Link: | GENVOYA at DailyMed |
Generic Entry Opportunity Date for GENVOYA
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for GENVOYA
US Patents and Regulatory Information for GENVOYA
Expired US Patents for GENVOYA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | GENVOYA | cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 207561-001 | Nov 5, 2015 | ➤ Sign Up | ➤ Sign Up |
| Gilead Sciences Inc | GENVOYA | cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 207561-001 | Nov 5, 2015 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for GENVOYA
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 101796040 | ➤ Sign Up |
| Brazil | PI0911871 | ➤ Sign Up |
| Lithuania | C2049506 | ➤ Sign Up |
| Lithuania | 2744810 | ➤ Sign Up |
| Serbia | 55280 | ➤ Sign Up |
| Czech Republic | 304886 | ➤ Sign Up |
| Spain | 2076130 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for GENVOYA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0061 | France | ➤ Sign Up | PRODUCT NAME: ELVITEGRAVIR OU UN HYDRATE, SOLVATE, TAUTOMERE, OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CEUX-CI; REGISTRATION NO/DATE: EU/1/13/830/001-002 20130524 |
| 2017 00004 | Denmark | ➤ Sign Up | PRODUCT NAME: COBICISTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF OG TENOFOVIRALAFENAMID ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER TENOFOVIRALAFENAMIDFUMARAT; REG. NO/DATE: EU/1/15/1061/001-002 20151123 |
| 13/052 | Ireland | ➤ Sign Up | PRODUCT NAME: ELVITEGRAVIR OR A HYDRATE, SOLVATE, TAUTOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/13/830/001-002 20130527 |
| 2015040 | Lithuania | ➤ Sign Up | PRODUCT NAME: COBICISTATUM; REGISTRATION NO/DATE: EU/1/13/830/001 - 002 20130524 |
| 2016000120 | Germany | ➤ Sign Up | PRODUCT NAME: COBICISTAT ODER EIN PHARMAZEUTISCHES AKZEPTABLES SALZ DAVON UND ATAZANAVIR ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, INSBESONDERE ATAZANAVIRSULFAT; REGISTRATION NO/DATE: EU/1/15/1025 20150713 |
| 0859 | Netherlands | ➤ Sign Up | PRODUCT NAME: COBICISTAT, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN ATAZANAVIR, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER ATAZANAVIRSULFAAT; REGISTRATION NO/DATE: EU/1/15/1025 20150715 |
| 2013 00058 | Denmark | ➤ Sign Up | PRODUCT NAME: ELVITEGRAVIR ELLER ET HYDRAT, ET SOLVAT, EN TAUTOMER ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/13/830/001-002 20130527 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
